Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor PK/PD in ACS Patients After CABG or Cardiac Arrest
NCT02341729Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Mar 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor in acute coronary syndrome (ACS) (2 arms), sponsored by Ghent University Hospital. Primary endpoints: Platelet Function Analysis (closing time) at Day 4, Aggreguide aggregometry at Day 4 and 1 more. Started Mar 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02341729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341729.